scientific advice

The evaluation and monitoring of medicinal products is based on knowledge about the many properties of a medicine, which can be defined as a product manufactured from a pharmacologically active substance. This knowledge is developed within:

  • industry
  • academic institutions
  • and clinical practice

The MEB uses this knowledge in order to make a final assessment
on the licensing of the medicine and the conditions under which it may be used and then passes this accumulated knowledge on to decisionmakers and users. The ultimate aim of this process is to promote the careful use of medicines. One of our strategic priorities is to strengthen the MEB as a link and partner in this continuum of pharmaceutical knowledge.

What kind of advices are provided by the MEB?

During the development of a medicinal product, advice can be requested from the MEB. This also applies for medicated medical devices. A request for advice may be submitted to the MEB not only during the development phase but also immediately before the actual submission of the marketing authorisation application. The advice can be related to the scientific content of the dossier or the authorisation procedure to be followed.

The advice is given on the basis of current scientific knowledge and in accordance with the prevailing guidelines. It cannot be seen to be predictive of the final opinion of the MEB and/or the CHMP following assessment of the entire dossier. The MEB will of course treat all data it receives in confidence.

Regulatory advice relates mainly to questions on the legal basis of an application. This can sometimes be given together with scientific advice, and sometimes separately.

Visit regulatory affairs > products & fees for an overview of costs regarding to scientific advice.

Questions?
For general matters please contact our scientific advice programme desk at 0031 (0)70 -356 7519, email: pb.wetenschap@cbg-meb.nl. For questions about the procedure or planning, please send an email to: case@cbg-meb.nl (add the case number in the subject line: case number [number]).

Does your question relate to an application that is currently in process, please submit it to the following e-mail address: case@cbg-meb.nl. In the subject line the case number should be stated in the format: case number [number].

More informatie
Medical devices

Back